Comparison of radiolabeled choline and ethanolamine as probe for cancer detection

Cancer Biology and Therapy

Volumn 7, Issue 5, 2008, Pages 742-747

  Mintz, Akiva ^a   Wang, Limin ^a   Ponde, Datta E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer detection; Chemical probe; Phospholipids metabolism; Prostate cancer; Radiolabeled choline; Radiolabeled ethanolamine; 14C cell uptake study

Indexed keywords

ANDROGEN; CHOLINE; DEANOL; ETHANOLAMINE; TRACER; CARBON; DIAGNOSTIC AGENT; ETHANOLAMINE DERIVATIVE; FLUORINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL PROLIFERATION; CELL STRAIN A172; COMPARATIVE STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; FIBROBLAST; HUMAN; HUMAN CELL; ISOTOPE LABELING; CHEMISTRY; INSTRUMENTATION; METABOLISM; NEOPLASM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR CELL LINE;

CARBON RADIOISOTOPES; CELL LINE, TUMOR; CHOLINE; ETHANOLAMINE; ETHANOLAMINES; FIBROBLASTS; FLUORINE RADIOISOTOPES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHORYLCHOLINE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 56149099975     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.5.5746     Document Type: Article

References (22)

1. Oyama N, Kim J, Jones LA, Mercer NM, Engelbach JA, Sharp TL, Welch MJ. MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model. Nucl Med Biol 2002; 29:783-90.
2. Oyama N, Akino H, Suzuki Y, Kanamaru H, Ishida H, Tanase K, Sadato N, Yonekura Y, Okada K. FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nucl Med Commun 2001; 22:963-9.
3. 18F]-fluoro-D-glucose. Radiology 1996; 199:751-6.
4. Hara T, Kosaka N, Shinoura N, Kondo T. PET Imaging of brain tumor with [methyl-11C] choline. J Nucl Med 1997; 38:842-47.
5. Hara T, Kosaka N, Kishi H. Development of 18F-Fluoroethylcholine for Cancer Imaging with PET: Synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 2002; 43:187-99.
6. 31P NMR spectroscopy. J Biol Chem 1987; 262:14875-78.
7. Daly PF, Cohen JS. Magnetic resonance spectroscopy of tumors and potential in vivo clinical application: A Review. Cancer Res 1989; 49:770-9.
8. Podo F. Tumor phospholipids metabolism, NMR in Biomedicine 1999; 12:413-39.
9. Negendank WG, Padavicshaller KA, Li CW, Murrhyboesch J, Stoyanova R, Krigel RL, Schilder RJ, Smith MR, Brown TR. Metabolic characterization of human non-Hodgkin's lymphomas in vivo with the use of proton-decoupled phosphorous magnetic resonance spectroscopy. Cancer Res 1995; 55:3286-94.
10. 31P-NMR on developing dog brain. FEBS Letters 1984; 178:137-42.
11. 31P NMR spectra of human breast tumors in vivo. NMR Biomed 1992; 5:37-42.
12. 31P MRS study. Br J Cancer 1993; 67:1145-53.
13. 14C-radiolabeled compounds in vivo. Biochem. Biophys. Acta 1993; 1181:111-21.
14. 31P-NMR spectroscopy: in vivo monitoring of the local anti-tumor effects of systemic immune cell transfer. Int J Cancer 1996; 66:484-95.
15. 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001; 42:1805-14.
16. 31F] FDG in cultured prostate cancer cells. Nuclear Medicine and Biology 2006; 33:977-84.
17. Kennedy EP. The biosynthesis of phospholipids. In Lipids and Membranes: Past, Present and Future. ed by J.A.F. OpdenKamp, B. Roclofsen, K.W.A. Wirtz, pp. 171-206, Elsevier Science, Amsterdam 1986.
18. Tijburg LBM, Geelen MJH, van Golde LMG. Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine in the liver. Biochim. Biophys. Acta 1989; 1004:1-19.
19. Jackowski S. Coordination of membrane phospholipids synthesis with the cell cycle. J Biol Chem 1994; 269:3858-67.
20. Murillo H, Huang H, Schmidt LJ, Smith DI, Tindall DJ. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001; 142:4795-805.
21. Tavassoli P, Snoek R, Ray M, Rao LG, Rennie PS. Rapid, Non-destructive, cell-based screening assays for agents ahat modulate growth, death, and androgen receptor activation in prostate cancer cells. The Prostate 2007; 67:416-26.
22. Ponde DE, Mintz A. Comparison of radiolabled choline and ethanolamine as a probe that measure cellular proliferation. J Nucl Med 2007; 48:33.